A model of care for familial hypercholesterolaemia: key role for clinical biochemistry
作者： Ian Hamilton-Craig , Nicola Poplawski , Peter M George , John R Burnett , David R Sullivan
DOI:
关键词:
摘要: Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that causes marked elevation in plasma low-density lipoprotein (LDL) cholesterol concentrations and premature coronary heart disease. There are at least 45,000 people with FH Australia New Zealand, but most remain unrecognised those diagnosed inadequately treated. To bridge this gap prevention the Australasia Network has developed model of care for FH. An executive summary presented, commentary on its recommendations key role clinical biochemistry laboratory.
researchgate.net 参考文章(28)
David P Tognarini, Ken Sikaris, David R Sullivan, Alan McNeil, David W Thomas, Grahame Caldwell, Matthew Meerkin, Charles A Appleton, Recommendations for lipid testing and reporting by Australian pathology laboratories. The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists. ,vol. 28, pp. 32- 45 ,(2007)
, Z. Reiner, A. L. Catapano, G. De Backer, I. Graham, M.-R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M. J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P. P. Filardi, G. Riccardi, R. F. Storey, D. Wood, J. Bax, A. Vahanian, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, G. Filippatos, C. Funck-Brentano, D. Hasdai, R. Hobbs, A. Hoes, P. Kearney, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, A. Torbicki, P. Vardas, P. Widimsky, S. Windecker, D. Reviewers:, C. Funck-Brentano, D. Poldermans, G. Berkenboom, J. De Graaf, O. Descamps, N. Gotcheva, K. Griffith, G. F. Guida, S. Gulec, Y. Henkin, K. Huber, Y. A. Kesaniemi, J. Lekakis, A. J. Manolis, P. Marques-Vidal, L. Masana, J. McMurray, M. Mendes, Z. Pagava, T. Pedersen, E. Prescott, Q. Rato, G. Rosano, S. Sans, A. Stalenhoef, L. Tokgozoglu, M. Viigimaa, M. E. Wittekoek, J. L. Zamorano, , , ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆ Atherosclerosis. ,vol. 32, pp. 1769- 1818 ,(2011) , 10.1093/EURHEARTJ/EHR158
Erik Aarden, Ine Van Hoyweghen, Klasien Horstman, The paradox of public health genomics: definition and diagnosis of familial hypercholesterolaemia in three European countries. Scandinavian Journal of Public Health. ,vol. 39, pp. 634- 639 ,(2011) , 10.1177/1403494811414241
, Philip Greenland, Joseph S. Alpert, George A. Beller, Emelia J. Benjamin, Matthew J. Budoff, Zahi A. Fayad, Elyse Foster, Mark. A. Hlatky, John McB. Hodgson, Frederick G. Kushner, Michael S. Lauer, Leslee J. Shaw, Sidney C. Smith, Allen J. Taylor, William S. Weintraub, Nanette K. Wenger, 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation. ,vol. 122, pp. 2748- 2764 ,(2010) , 10.1161/CIR.0B013E3182051B4C
Jennifer G. Robinson, Anne C. Goldberg, Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of Clinical Lipidology. ,vol. 5, ,(2011) , 10.1016/J.JACL.2011.03.451
Steve E Humphries, Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus? Atherosclerosis Supplements. ,vol. 12, pp. 217- 220 ,(2011) , 10.1016/S1567-5688(11)00037-7
M Thorogood, M Seed, K De Mott, , Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance British Journal of Obstetrics and Gynaecology. ,vol. 116, pp. 478- 479 ,(2009) , 10.1111/J.1471-0528.2008.02084.X
Frederick J. Raal, Gillian J. Pilcher, Vanessa R. Panz, Hendrick E. van Deventer, Brigitte C. Brice, Dirk J. Blom, A. David Marais, Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy Circulation. ,vol. 124, pp. 2202- 2207 ,(2011) , 10.1161/CIRCULATIONAHA.111.042523
Steve E Humphries, Gail Norbury, Sarah Leigh, S Gaye Hadfield, Devikair Nair, What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia? Current Opinion in Lipidology. ,vol. 19, pp. 362- 368 ,(2008) , 10.1097/MOL.0B013E32830636E5
Timothy R. Bates, John R. Burnett, Frank M. van Bockxmeer, Sandra Hamilton, Leonard Arnolda, Gerald F. Watts, Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology. Heart Lung and Circulation. ,vol. 17, pp. 411- 413 ,(2008) , 10.1016/J.HLC.2007.06.005